News in gay Atlanta of a drug that can eradicate previously incurable Hepatitis-C in 99 percent of cases was tainted last week by the state picking and choosing who can get it, excluding thousands of HIV-positive patients. It’s renewed a clarion call by activists to expand Medicaid.
The 12-week drug regimen known as V-Pak works, but it’s expensive – as much as $80,000 per patient. The National Alliance of State and Territorial AIDS Directors, which includes Georgia, negotiated a discount to about half price, but each state must decide whether or not to offer it under various programs.
In Georgia, that meant Hepatitis C patients under Medicaid will get V-Pak. But HIV-positive people with Hep C on ADAP, the HIV prescription assistance program, can’t. State agencies say they’re hamstrung by the cost to offer life-saving treatment to some and deny it to others, according to WABE.
Read more...
Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.
Alan Franciscus
Editor-in-Chief
HCV Advocate
Showing posts with label Georgia. Show all posts
Showing posts with label Georgia. Show all posts
Friday, February 6, 2015
Thursday, January 29, 2015
Expensive Hepatitis C Cure ─ Georgia Decides Who Gets It, Who Doesn't
There’s a new drug on the market that’s up to 99 percent effective at curing hepatitis C, an often deadly liver virus. The drug is known as “V-pak.”
Some Georgians will get it.
But thousands of HIV-positive Georgians, who also have hepatitis C, won't.
The reason? Cost.
Read more and listen to the podcast here....
Some Georgians will get it.
But thousands of HIV-positive Georgians, who also have hepatitis C, won't.
The reason? Cost.
Read more and listen to the podcast here....
Labels:
access restrictions,
Georgia,
medicaid,
NPR,
V-pak
Subscribe to:
Posts (Atom)